Various Strategies Used by U.S. Adults to Manage Chronic Pain

MONDAY, Feb. 7, 2022 (HealthDay News) -- Adults with chronic pain use a variety of pain management strategies, including opioids, but the majority use nonopioid management techniques, according to a research letter published online Feb. 7 in JAMA Network Open.
Cornelius B. Groenewald, M.B., Ch.B., from the Seattle Children's Research Institute, and colleagues examined the use of pain management techniques for chronic pain among adults using data from the 2019 National Health Interview Survey. Data were included for 31,916 participants (64 percent female).
The researchers found that 54.7 percent of adults with chronic pain only used nonopioid pain management techniques, while 10.7, 4.4, and 30.2 percent used both opioids and nonopioid techniques, used opioids only, and did not report any pain management techniques during the past three months. Complementary therapies represented the most commonly used nonopioid pain management technique, and were used by 35.4 percent of participants, followed by physical, occupational, or rehabilitative therapies, which were used by 18.8 percent. Psychological or psychotherapeutic interventions were only used by 3.8 percent. Self-management programs and chronic pain peer support groups were used by 5.1 and 1.8 percent, respectively. Overall, 39.1 percent of adults reported using pain approaches not captured in this data set. Prescription opioid use was more common among older adults and among women versus men.
"Nonpharmacologic and nonopioid pharmacologic therapies are preferred treatments for chronic pain, and it is encouraging to note that most adults with chronic pain use a combination of various nonopioid modalities for treatment," the authors write.
Related Posts
Los niños privados de sueño comen más refrigerios, según un estudio
LUNES, 24 de octubre de 2022 (HealthDay News) -- Unos expertos que estudian los...
Un estudio multigeneracional encuentra vínculos entre el TDAH y el riesgo de demencia
MARTES, 14 de septiembre de 2021 (HealthDay News) -- El trastorno de déficit de...
Prevalence of VEXAS Syndrome Identified in U.S. Health System
WEDNESDAY, Jan. 25, 2023 (HealthDay News) -- The prevalence and clinical...
Oral Azithromycin Equivalent to Six Weeks Doxycycline for Meibomian Gland Dysfunction
FRIDAY, March 31, 2023 (HealthDay News) -- Three weeks of oral azithromycin...
